Nutzen und Grenzen der fokalen Therapie des Nierenzellkarzinoms
Crossref DOI link: https://doi.org/10.1007/s00092-018-1897-z
Published Online: 2018-06-02
Published Print: 2018-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Jones, Jon
Text and Data Mining valid from 2018-06-01
Article History
First Online: 2 June 2018